A detailed history of Bellevue Group Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bellevue Group Ag holds 7,874,400 shares of IONS stock, worth $288 Million. This represents 5.32% of its overall portfolio holdings.

Number of Shares
7,874,400
Previous 8,260,434 4.67%
Holding current value
$288 Million
Previous $394 Million 19.87%
% of portfolio
5.32%
Previous 6.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $15.5 Million - $20 Million
-386,034 Reduced 4.67%
7,874,400 $315 Million
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $1.42 Million - $1.86 Million
-39,080 Reduced 0.47%
8,260,434 $394 Million
Q1 2024

May 15, 2024

SELL
$42.03 - $53.55 $17.4 Million - $22.2 Million
-414,473 Reduced 4.76%
8,299,514 $360 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $22.6 Million - $26.8 Million
-519,713 Reduced 5.63%
8,713,987 $441 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $5.64 Million - $6.91 Million
-146,600 Reduced 1.56%
9,233,700 $419 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $4.57 Million - $5.7 Million
-131,600 Reduced 1.38%
9,380,300 $385 Million
Q1 2023

May 15, 2023

SELL
$33.58 - $41.2 $7.79 Million - $9.56 Million
-232,000 Reduced 2.38%
9,511,900 $340 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $10.4 Million - $13 Million
280,500 Added 2.96%
9,743,900 $368 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $11.4 Million - $15.2 Million
-313,128 Reduced 3.2%
9,463,400 $419 Million
Q2 2022

Aug 11, 2022

SELL
$31.71 - $43.0 $4.49 Million - $6.09 Million
-141,545 Reduced 1.43%
9,776,528 $362 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $13.1 Million - $16.2 Million
-437,050 Reduced 4.22%
9,918,073 $367 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $25.8 Million - $35.4 Million
1,007,197 Added 10.77%
10,355,123 $315 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $19.5 Million - $23.6 Million
-582,319 Reduced 5.86%
9,347,926 $314 Million
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $32.7 Million - $44.7 Million
946,011 Added 10.53%
9,930,245 $396 Million
Q1 2021

May 12, 2021

SELL
$42.51 - $63.78 $2.8 Million - $4.2 Million
-65,858 Reduced 0.73%
8,984,234 $404 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $15.1 Million - $20.1 Million
333,822 Added 3.83%
9,050,092 $512 Million
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $22.1 Million - $29.4 Million
466,397 Added 5.65%
8,716,270 $414 Million
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $6.08 Million - $7.92 Million
-129,769 Reduced 1.55%
8,249,873 $486 Million
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $2.17 Million - $3.31 Million
-52,178 Reduced 0.62%
8,379,642 $396 Million
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $5.92 Million - $7.17 Million
109,906 Added 1.32%
8,431,820 $509 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $21.5 Million - $26.3 Million
364,786 Added 4.58%
8,321,914 $499 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $475 Million - $659 Million
7,654,485 Added 2529.21%
7,957,128 $511 Million
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $4.23 Million - $6.49 Million
-79,945 Reduced 20.9%
302,643 $24.6 Million
Q4 2018

Feb 12, 2019

BUY
$43.37 - $59.54 $3.12 Million - $4.29 Million
72,052 Added 23.2%
382,588 $20.7 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $516,704 - $647,085
-12,050 Reduced 3.74%
310,536 $16 Million
Q2 2018

Aug 07, 2018

BUY
$40.53 - $50.7 $421,512 - $527,280
10,400 Added 3.33%
322,586 $13.4 Million
Q1 2018

May 09, 2018

BUY
$44.08 - $55.05 $2.45 Million - $3.05 Million
55,480 Added 21.61%
312,186 $13.8 Million
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $452,700 - $579,510
-9,000 Reduced 3.39%
256,706 $12.9 Million
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $1.87 Million - $2.45 Million
41,144 Added 18.32%
265,706 $13.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
224,562
224,562 $11.4 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.